MobileODT For Profit
![](/files/companies/MobileODT.png)
A complete diagnostics and treatment solution for cervical cancer, including EVA Pro digital colposcope with a built-in camera and advanced software applications, Delphi HPV 16/18/31/33/45/52/58 Antigen Rapid test with no lab needed, and ThermoGlide thermocoagulation treatment for precancerous lesions.
Investment Stage:
N/A
Founded Date:
2012-10-01
Investor Type:
N/A
Estimated Revenue:
$2Mper year
Total Funding:
14130000
Investors Number:
9
Employee Number:
11-50
Number Of Exists:
N/A
Last Funding Type:
Series C
Industry:
Clinical Data Management
Technology:
Biomarker panels
Headquarters:
Tel Aviv, Tel Aviv, Israel
Funding Status:
Late Stage Venture
Last Funding Date:
2020-08-12